Skip to content

DRG stimulation in patients with chronic knee pain before and after total knee arthroplasty

DRG stimulation in patients with chronic knee pain before and after total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028516
Enrollment
60
Registered
2022-06-03
Start date
2022-08-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M25.56

Interventions

Group 1: Patients with chronic therapy-refractory knee pain after receiving a knee endoprosthesis with already implanted DRG stimulation Group 2: Patients with chronic therapy-refractory knee pain bef

Sponsors

Klinik und Poliklinik für Neurochirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years, ability to consent, compliance, chronic pain symptoms in the knee: > 3 months duration, intermittently several times a week or permanent pain, insufficient improvement through conservative therapy, associated: subj. suffering, functional impairment, reduced quality of life. Knee TKP performed or indicated. Group according to TKR: TKR received according to S2k guideline, exclusion of mechanical cause by means of knee X-ray, if necessary CT/ MRI/ sono, exclusion of infection (normal CRP, unremarkable knee inspection). Group before TKA: Indication according to S2k guideline, TKA not yet performed. Group DRG stimulation: > 3 months after knee TEP, successfully completed test phase (pain reduction VAS > 50%), definitive pulse generator implanted. Group without DRG stimulation: DRG stimulation indicated, DRG stimulation not performed without patient request, contraindications (coagulation disorder; oral anticoagulation that cannot be paused/platelet function inhibitors; chronic wound healing disorders, lumbar infection, ASS > 3, incompatible pacemaker/incompatible deep brain stimulation system)

Exclusion criteria

Exclusion criteria: Age < 18 years, lack of capacity to consent, lack of compliance, substance abuse (drugs, alcohol), already implanted active or ineffective SCS/DRG system due to other indication, acute severe psychiatric illness requiring treatment, incompatible pacemaker, incompatible system for deep brain stimulation, knee infection: increased CRP , clinical signs at knee inspection. Treatable mechanical cause after TKA (detection in the X-ray image, if necessary CT/MRT/sonography, pathologies of the lumbar spine or in adjacent joints (hip, ankle) with pain radiating into the knee

Design outcomes

Primary

MeasureTime frame
Patients with chronic therapy-refractory knee pain before/after receiving a knee endoprosthesis benefit from neurostimulation using DRG stimulation compared to a control group without neuromodulatory stimulation. Pain reduction >50% by visual analogue scale compared to baseline. Pain intensity is assessed after 1 month, 3 months, 6 months, 12 months and 24 months.

Secondary

MeasureTime frame
Influence of the stimulation effect on quality of life, depression and functional limitations after one month, 3 months, 6 months, 12 months and 24 months.

Countries

Germany

Contacts

Public ContactFranziska Frank

Klinik und Poliklinik für Neurochirurgie

franziska.frank@medizin.uni-leipzig.de0341 97 20133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026